Back to search

Article

Treatment of Chronic Spontaneous Urticaria With Benralizumab: Report of Primary Endpoint Completer Analysis, Secondary and Exploratory Endpoints

2020-10-09

Abstract excerpt

<h4>Background: </h4> Standard of care for chronic spontaneous urticaria (CSU) includes second-generation H1-antihistamines (SGAH) but is often ineffective even with four-times the FDA-recommended dose. Urticarial lesions are commonly characterized by increased lymphocytes with perivascular eosinophilic infiltrates implying a role for the interleukin-5 (IL5). Objective. This study investigated the effects of benra...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
f7212eb3-b68a-578d-b6cd-ee5133902d50
DOI
10.22541/au.160226445.57744780/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Treatment of Chronic Spontaneous Urticaria With Benralizumab: Report of Primary Endpoint Completer Analysis, Secondary and Exploratory EndpointsDOI 10.22541/au.160226445.57744780/v1
Select a neighboring publication to make it the new centre.